Siddharth Singh (S Singh)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 61

Top Topics

Systematic Review

Top Venues

Alimentary pharmacology & therapeutics

Journal of Crohn's & colitis

Inflammatory bowel diseases

Digestive diseases and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Moses Fung, Yasamin Farbod, Husain Kankouni, Siddharth Singh, Jeffrey D McCurdy
Does combined medical and surgical treatment improve perianal fistula outcomes in patients with Crohn's disease? A systematic review and meta-analysis. Journal of Crohn's & colitis (2024)
Moses Fung, Yasamin Farbod, Husain Kankouni, Siddharth Singh, Jeffrey D McCurdy
Does Combined Medical and Surgical Treatment Improve Perianal Fistula Outcomes in Patients With Crohn's Disease? A Systematic Review and Meta-Analysis. Journal of Crohn's & colitis 18 (8) (2024)
Moses Fung, Yasamin Farbod, Husain Kankouni, Siddharth Singh, Jeffrey D McCurdy
Does Combined Medical and Surgical Treatment Improve Perianal Fistula Outcomes in Patients With Crohn's Disease? A Systematic Review and Meta-Analysis. Journal of Crohn's & colitis 18 (8) (2024)
Michael Jew, Joseph Meserve, Samuel Eisenstein, Vipul Jairath, Jeffrey McCurdy, Siddharth Singh
Temporary Faecal Diversion for Refractory Perianal and/or Distal Colonic Crohn's Disease in the Biologic Era: An Updated Systematic Review with Meta-Analysis. Journal of Crohn's & colitis (2023)
Patrick Hamilton, Katherine Buhler, John K MacDonald, Gilaad G Kaplan, Cynthia H-T Seow, Cathy Lu, Kerri L Novak, Christopher N Andrews, Siddharth Singh, Vipul Jairath, Remo Panaccione, Christopher Ma
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm. Alimentary pharmacology & therapeutics 57 (8) (2023)
Patrick Hamilton, Katherine Buhler, John K MacDonald, Gilaad G Kaplan, Cynthia H-T Seow, Cathy Lu, Kerri L Novak, Christopher N Andrews, Siddharth Singh, Vipul Jairath, Remo Panaccione, Christopher Ma
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm. Alimentary pharmacology & therapeutics (2023)
Lotus Alphonsus, Theshani A De Silva, Christopher Ma, John K MacDonald, Jurij Hanžel, Melanie Beaton, Talat Bessissow, Maia Kayal, Rocio Sedano, Siddharth Singh, Vipul Jairath
Systematic review and meta-analysis of randomised controlled trials: Medical therapies for the treatment and prevention of pouchitis. Alimentary pharmacology & therapeutics (2023)
Siddharth Singh
Positioning therapies for the management of inflammatory bowel disease. Nature reviews. Gastroenterology & hepatology (2023)
Patrick Hamilton, Katherine Buhler, John K MacDonald, Gilaad G Kaplan, Cynthia H-T Seow, Cathy Lu, Kerri L Novak, Christopher N Andrews, Siddharth Singh, Vipul Jairath, Remo Panaccione, Christopher Ma
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm. Alimentary pharmacology & therapeutics 57 (8) (2023)
Jurij Hanžel, Christopher Ma, Theshani Amalka De Silva, Lotus Alphonsus, Leonardo Guizzetti, Eileen Crowley, Siddharth Singh, Vipul Jairath
Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration. Inflammatory bowel diseases (2023)
Achuthan Aruljothy, Siddharth Singh, Neeraj Narula, Gordon William Moran, Sudheer K Vuyyuru, Malcolm Hogan, Alexa Zayadi, John K MacDonald, Benedicte Caron, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath
Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis. Alimentary pharmacology & therapeutics (2023)
Nik Sheng Ding, Daniel Tassone, Ibrahim Al Bakir, Kyle Wu, Alexander J Thompson, William R Connell, George Malietzis, Phillip Lung, Siddharth Singh, Chang-Ho Ryan Choi, Simon Gabe, John T Jenkins, Ailsa Hart
Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease. Journal of Crohn's & colitis 16 (9) (2022)
Mehak Bassi, Siddharth Singh
Impact of Obesity on Response to Biologic Therapies in Patients with Inflammatory Bowel Diseases. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (2) (2022)
Preethi G Venkat, Nghia H Nguyen, Jiyu Luo, Alexander S Qian, Sahil Khanna, Siddharth Singh
Impact of recurrent hospitalization for Clostridioides difficile on longitudinal outcomes in patients with inflammatory bowel diseases: a nationally representative cohort. Therapeutic advances in gastroenterology 15 (2022)
Hyuk Yoon, Sushrut Jangi, Parambir S Dulai, Brigid S Boland, Vipul Jairath, Brian G Feagan, William J Sandborn, Siddharth Singh
Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission. Inflammatory bowel diseases 27 (8) (2022)
Eddie Hill, Nghia H Nguyen, Alexander S Qian, Sagar Patel, Peter L Chen, Chung-Sang Tse, Siddharth Singh
Impact of Comorbid Psychiatric Disorders on Healthcare Utilization in Patients with Inflammatory Bowel Disease: A Nationally Representative Cohort Study. Digestive diseases and sciences 67 (9) (2022)
Jacob J Rozich, Jiyu Luo, Parambir S Dulai, Angelina E Collins, Lysianne Pham, Brigid S Boland, William J Sandborn, Siddharth Singh
Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset Disease. Inflammatory bowel diseases 27 (8) (2022)
James D Lewis, Raymond K Cross, Millie Long, Siddharth Singh, Hans H Herfarth, Alexandra Weiss, Anna Buchner
High Degree of Practice Variability in Colonic Dysplasia Surveillance for Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases 28 (8) (2022)
Siddharth Singh, Herbert C Heien, Lindsey Sangaralingham, Nilay D Shah, Jennifer C Lai, William J Sandborn, Alison A Moore
Frailty and Risk of Serious Infections in Biologic-treated Patients With Inflammatory Bowel Diseases. Inflammatory bowel diseases 27 (10) (2022)
Theshani A De Silva, Lotus Alphonsus, Christopher Ma, Malcolm Hogan, Rocio Sedano, Neeraj Narula, Silvio Danese, Laurent Peyrin-Biroulet, John K MacDonald, Siddharth Singh, Vipul Jairath
Placebo rates in randomized controlled trials of proctitis therapy: A systematic review and meta-analysis. Journal of Crohn's & colitis (2022)
Kendra J Kamp, Stephen E Hawes, Chung Sang Tse, Siddharth Singh, Nhu Dang, Ridhima Oberai, S Alandra Weaver, Gil Y Melmed, Corey A Siegel, Welmoed K van Deen, null null
Concordance and Discordance Between Patient-reported Remission, Patient-reported Outcomes, and Physician Global Assessment. Inflammatory bowel diseases (2022)
Preethi G Venkat, Nghia H Nguyen, Jiyu Luo, Alexander S Qian, Sahil Khanna, Siddharth Singh
Impact of recurrent hospitalization for Clostridioides difficile on longitudinal outcomes in patients with inflammatory bowel diseases: a nationally representative cohort. Therapeutic advances in gastroenterology 15 (2022)
Rocio Sedano, Malcolm Hogan, Tran M Nguyen, Joshua Chang, G Y Zou, John K Macdonald, Niels Vande Casteele, Jurij Hanzel, Eileen Crowley, Robert Battat, Parambir S Dulai, Siddharth Singh, Geert D'Haens, William Sandborn, Brian G Feagan, Christopher Ma, Vipul Jairath
Systematic review and Meta-analysis: Clinical, Endoscopic, Histologic and Safety Placebo Rates in Induction and Maintenance trials of Ulcerative Colitis. Journal of Crohn's & colitis (2021)
Nghia H Nguyen, Xian Zhang, Millie D Long, William J Sandborn, Michael D Kappelman, Siddharth Singh
Patient-Reported Outcomes and Risk of Hospitalization and Readmission in Patients with Inflammatory Bowel Diseases. Digestive diseases and sciences (2021)
Lester Tsai, Nghia H Nguyen, Christopher Ma, Larry J Prokop, William J Sandborn, Siddharth Singh
Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies. Digestive diseases and sciences (2021)
Sushrut Jangi, Hyuk Yoon, Parambir S Dulai, Mark Valasek, Brigid Boland, Vipul Jairath, Brian G Feagan, William J Sandborn, Siddharth Singh
Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis-authors' reply. Alimentary pharmacology & therapeutics 53 (8) (2021)
Nghia H Nguyen, Dominic Picetti, Parambir S Dulai, Vipul Jairath, William J Sandborn, Lucila Ohno-Machado, Peter L Chen, Siddharth Singh
Machine Learning-based Prediction Models for Diagnosis and Prognosis in Inflammatory Bowel Diseases: A Systematic Review. Journal of Crohn's & colitis (2021)
Carlos Lago-Hernandez, Nghia H Nguyen, Rohan Khera, Stephen Caldwell, Sumeet K Asrani, Siddharth Singh
Financial Hardship From Medical Bills Among Adults With Chronic Liver Diseases: National Estimates From the United States. Hepatology (Baltimore, Md.) 74 (3) (2021)
Ahmed Almradi, Rocio Sedano, Malcolm Hogan, G Y Zou, John K MacDonald, Claire E Parker, Jurij Hanzel, Eileen Crowley, Siddharth Singh, Geert D'Haens, William J Sandborn, Brian G Feagan, Christopher Ma, Vipul Jairath
Clinical, endoscopic and safety placebo rates in induction and maintenance trials of Crohn's disease: Meta-analysis of Randomised controlled trials. Journal of Crohn's & colitis (2021)
Lester Tsai, Jeffrey D McCurdy, Christopher Ma, Vipul Jairath, Siddharth Singh
Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts. Inflammatory bowel diseases (2021)
Siddharth Singh, Herbert C Heien, Lindsey Sangaralingham, Nilay D Shah, William J Sandborn
Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-α Antagonists in Patients with Inflammatory Bowel Diseases. Digestive diseases and sciences (2021)
Siddharth Singh, Alexander S Qian, Nghia H Nguyen, Stephanie K M Ho, Jiyu Luo, Vipul Jairath, William J Sandborn, Christopher Ma
Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016. Inflammatory bowel diseases (2021)
Joseph Meserve, Siddharth Singh
Editorial: risk of pneumonia in IBD-reading between the lines! Alimentary pharmacology & therapeutics 54 (11-12) (2021)
Dominic Picetti, Jihoon Kim, Wenhong Zhu, William J Sandborn, Vipul Jairath, Siddharth Singh
No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn's Disease Treated with Anti-metabolite Therapy. Digestive diseases and sciences (2021)
Ahmed Almradi, Christopher Ma, Geert R D'Haens, William J Sandborn, Claire E Parker, Leonardo Guizzetti, Paula Borralho Nunes, Gert De Hertogh, Roger M Feakins, Reena Khanna, Gregory Y Lauwers, Aart Mookhoek, Reetesh K Pai, Laurent Peyrin Biroulet, Robert Riddell, Christophe Rosty, David F Schaeffer, Mark A Valasek, Siddharth Singh, Eileen Crowley, Brian G Feagan, Vipul Jairath, Rish K Pai
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials. Alimentary pharmacology & therapeutics 53 (7) (2021)
Nour Hamade, Amrit K Kamboj, Rajesh Krishnamoorthi, Siddharth Singh, Leslie C Hassett, David A Katzka, Charles J Kahi, Hala Fatima, Prasad G Iyer
Systematic review with meta-analysis: neoplasia detection rate and post-endoscopy Barrett's neoplasia in Barrett's oesophagus. Alimentary pharmacology & therapeutics 54 (5) (2021)
Sushrut Jangi, Hyuk Yoon, Parambir S Dulai, Mark Valasek, Brigid S Boland, Vipul Jairath, Brian G Feagan, William J Sandborn, Siddharth Singh
Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing. Alimentary pharmacology & therapeutics 52 (6) (2020)
Matthew Bohm, Ronghui Xu, Yiran Zhang, Sashidhar Varma, Monika Fischer, Gursimran Kochhar, Brigid Boland, Siddharth Singh, Robert P Hirten, Ryan C Ungaro, Eugenia Shmidt, Karen Lasch, Vipul Jairaith, David Hudesman, Shannon Chang, Dana Lukin, Arun Swaminath, Bruce E Sands, Jean Frederic Colombel, Sunanda Kane, Edward V Loftus, Bo Shen, Corey A Siegel, William J Sandborn, Parambir S Dulai, null null
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease. Alimentary pharmacology & therapeutics 52 (4) (2020)
Alexandra Istl, Mei L Yang, Katherine A Fleshner, Claire E Parker, Leonardo Guizzetti, Siddharth Singh, Vipul Jairath
Letter: pre-operative anti-TNF therapy in Crohn's disease is not associated with increased complications following elective surgery. Alimentary pharmacology & therapeutics 50 (4) (2020)
Siddharth Singh, Vipul Jairath
Letter: immunogenicity of anti-TNF in elderly IBD patients-authors' reply. Alimentary pharmacology & therapeutics 50 (3) (2020)
Edward Yang, Nicola Panaccione, Natalie Whitmire, Parambir S Dulai, Niels Vande Casteele, Siddharth Singh, Brigid S Boland, Angelina Collins, William J Sandborn, Remo Panaccione, Robert Battat
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease. Alimentary pharmacology & therapeutics 51 (11) (2020)
Ariela K Holmer, Siddharth Singh
Editorial: pancreatic cancer risk in inflammatory bowel diseases-it's all relative. Alimentary pharmacology & therapeutics 52 (3) (2020)
Siddharth Singh, Vipul Jairath, Stitt Lw, Zou G, Khanna R, Dulai Ps, Sandborn Wj, Feagan Bg
Editorial: combination immunosuppressive therapy to treat Crohn's disease - ready for all age groups? Authors' reply. Alimentary pharmacology & therapeutics 49 (12) (2020)
Christopher Ma, Siddharth Singh, Joan Heatherington, Remo Panaccione
Editorial: is age just a number when it comes to treatment of inflammatory bowel disease? Alimentary pharmacology & therapeutics 52 (10) (2020)
Siddharth Singh, Jihoon Kim, Wenhong Zhu, Parambir S Dulai, William J Sandborn, Vipul Jairath
No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy. Alimentary pharmacology & therapeutics 52 (3) (2020)
Robert Battat, Niels Vande Casteele, Rish K Pai, Zhongya Wang, Guangyong Zou, John W D McDonald, Marjolijn Duijvestein, Jenny Jeyarajah, Claire E Parker, Tanja Van Viegen, Sigrid A Nelson, Brigid S Boland, Siddharth Singh, Parambir S Dulai, Mark A Valasek, Brian G Feagan, Vipul Jairath, William J Sandborn
Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study. Alimentary pharmacology & therapeutics 52 (10) (2020)
Gursimran S Kochhar, Aakash Desai, Aslam Syed, Abhinav Grover, Sandra El Hachem, Heitham Abdul-Baki, Preethi Chintamaneni, Elie Aoun, Sowjanya Kanna, Dalbir S Sandhu, Siddharth Singh, Bo Shen, Edward V Loftus, Parambir S Dulai
Risk of de-novo inflammatory bowel disease among obese patients treated with bariatric surgery or weight loss medications. Alimentary pharmacology & therapeutics 51 (11) (2020)
Edward Yang, Nicola Panaccione, Natalie Whitmire, Parambir S Dulai, Niels Vande Casteele, Siddharth Singh, Brigid S Boland, Angelina Collins, William J Sandborn, Remo Panaccione, Robert Battat
Letter: combination of biologics in inflammatory bowel diseases. Authors' reply. Alimentary pharmacology & therapeutics 52 (3) (2020)
Joseph Meserve, Antonio Facciorusso, Ariela K Holmer, Vito Annese, William J Sandborn, Siddharth Singh
Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases. Alimentary pharmacology & therapeutics 53 (3) (2020)
Siddharth Singh
Editorial: predicting recurrence of Crohn's disease after surgical resection-close to a crystal ball. Alimentary pharmacology & therapeutics 48 (10) (2019)
Parambir S Dulai, Aurelien Amiot, Laurent Peyrin Biroulet, Vipul Jairath, Melanie Serrero, Jerome Filippi, Siddharth Singh, Benjamin Pariente, Edward V Loftus, Xavier Roblin, Sunanda Kane, Anthony Buisson, Corey A Siegel, Yoram Bouhnik, William J Sandborn, Karen Lasch, Maria Rosario, Brian G Feagan, Daniela Bojic, Caroline Trang-Poisson, Bo Shen, Romain Altwegg, Bruce E Sands, Jean Frederic Colombel, Franck Carbonnel, null null
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease. Alimentary pharmacology & therapeutics 51 (5) (2019)
Siddharth Singh, Larry W Stitt, Guangyong Zou, Reena Khanna, Parambir S Dulai, William J Sandborn, Brian G Feagan, Vipul Jairath
Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT. Alimentary pharmacology & therapeutics 49 (9) (2019)
Michael Sai Lai Sey, Seid B Mohammed, Mayur Brahmania, Siddharth Singh, Brennan C Kahan, Vipul Jairath
Comparative outcomes in patients with ulcer- vs non-ulcer-related acute upper gastrointestinal bleeding in the United Kingdom: a nationwide cohort of 4474 patients. Alimentary pharmacology & therapeutics 49 (5) (2019)
Parambir S Dulai, Siddharth Singh, Vipul Jairath, Christopher Ma, Neeraj Narula, Niels Vande Casteele, Laurent Peyrin Biroulet, Severine Vermeire, Geert D'Haens, Brian G Feagan, William J Sandborn
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis. Alimentary pharmacology & therapeutics 51 (4) (2019)
Siddharth Singh, Parambir S Dulai, Niels Vande Casteele, Robert Battat, Mathurin Fumery, Brigid S Boland, William J Sandborn
Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases. Alimentary pharmacology & therapeutics 50 (8) (2019)
Siddharth Singh, Antonio Facciorusso, Abha G Singh, Niels Vande Casteele, Amir Zarrinpar, Larry J Prokop, Eduardo L Grunvald, Jeffrey R Curtis, William J Sandborn
Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis. PloS one 13 (5) (2018)
Siddharth Singh, M Fumery, William J Sandborn, M H Murad
Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn's disease. Alimentary pharmacology & therapeutics 48 (4) (2018)
Christopher Ma, S J Dutton, L E Cipriano, Siddharth Singh, C E Parker, T M Nguyen, L Guizzetti, J C Gregor, N Chande, P Hindryckx, Brian G Feagan, Vipul Jairath
Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease. Alimentary pharmacology & therapeutics 48 (2) (2018)
S Kurnool, N H Nguyen, J Proudfoot, Parambir S Dulai, B S Boland, N Vande Casteele, E Evans, E L Grunvald, A Zarrinpar, William J Sandborn, Siddharth Singh
High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis. Alimentary pharmacology & therapeutics 47 (11) (2018)
Siddharth Singh, N N Andersen, M Andersson, E V Loftus, Tine Jess
Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study. Alimentary pharmacology & therapeutics 47 (5) (2017)
Siddharth Singh, M Fumery, W J Sandborn, M H Murad
Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis. Alimentary pharmacology & therapeutics 47 (2) (2017)